Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147639 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Zhongyan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Neoplasms, Ubiquitination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Province Basic and Applied Basic Research Fund, National Natural Science Foundation of China, Center for Intelligent Drug Systems and Smart Bio-device.
Abstract (Originalsprache)
Ubiquitination, a post-translational modification, refers to the covalent attachment of ubiquitin molecules to substrates. This modification plays a critical role in diverse cellular processes such as protein degradation. The specificity of ubiquitination for substrates is regulated by E3 ubiquitin ligases. Dysregulation of ubiquitination has been associated with numerous diseases, including cancers. In our study, we first investigated the protein expression patterns of E3 ligases across 12 cancer types. Our findings indicated that E3 ligases tend to be up-regulated and exhibit reduced tissue specificity in tumors. Moreover, the correlation of protein expression between E3 ligases and substrates demonstrated significant changes in cancers, suggesting that E3-substrate specificity alters in tumors compared to normal tissues. By integrating transcriptome, proteome, and ubiquitylome data, we further characterized the E3-substrate regulatory patterns in lung squamous cell carcinoma. Our analysis revealed that the upregulation of the SKP2 E3 ligase leads to excessive degradation of BRCA2, potentially promoting tumor cell proliferation and metastasis. Furthermore, the upregulation of E3 ubiquitin–protein ligase TRIM33 was identified as a biomarker associated with a favorable prognosis by inhibiting the cell cycle. This work exemplifies how leveraging multi-omics data to analyze E3 ligases across various cancers can unveil prognosis biomarkers and facilitate the identification of potential drug targets for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Department of Biological Science and Technology, National Yang Ming Chiao Tung University, No. 75, Boai Street, Hsinchu 300, Taiwan.
ORCID-Profile: Jingting Wan, Tzong-Yi Lee
Förderung
- Guangdong Province Basic and Applied Basic Research Fund
- National Natural Science Foundation of China
- Center for Intelligent Drug Systems and Smart Bio-device
- Yushan Young Fellow Program
- National Science and Technology Council
- The National Health Research Institutes in Taiwan
- The National Health Research Institutes
Zitieren
APA
Li, Z., Wan, J., Li, S., Tang, Y., Lin, Y. C., Ni, J., Cai, X., Yu, J., Huang, H. D., & Lee, T. Y. (2024). Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147639
Vancouver
Li Z, Wan J, Li S, Tang Y, Lin YC, Ni J, et al. Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147639
BibTeX
@article{Li2024,
author = {Li, Zhongyan and Wan, Jingting and Li, Shangfu and Tang, Yun and Lin, Yang-Chi-Dung and Ni, Jie and Cai, Xiaoxuan and Yu, Jinhan and Huang, Hsien-Da and Lee, Tzong-Yi},
title = {Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147639}
}
EUVIMED